Viewing Study NCT04908956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-06-27 @ 4:33 AM
Study NCT ID: NCT04908956
Status: TERMINATED
Last Update Posted: 2024-06-28
First Post: 2021-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)
Sponsor: ETOP IBCSG Partners Foundation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC Stage IV View
None EGFR Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None EGFR mutation (exon 19 deletion and/or exon 21 L858R) View
None Osimertinib View
None SBRT View